Compare Freeport-McMoRan Inc (FCX) vs Zoetis Inc (ZTS) Price & Performance

Freeport-McMoRan (FCX) trades at $73.69, up 2.54% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with $25.9B revenue, 11.38% net margin, and positive cash flow trends. Recent news highlights copper demand growth from AI/data centers, positioning FCX to benefit from favorable commodity trends while managing cost pressures.

FCX presents a mixed outlook with analyst consensus at Buy (61%) and $73.27 price target near current levels. Upside potential exists from copper's structural deficit and expansion projects, but risks include rising production costs, margin pressure, and ongoing legal investigation. The stock offers exposure to copper's AI-driven demand while facing execution challenges in a volatile commodity environment.

Zoetis (ZTS) trades at $74.38, up 3.96% in the last session, with a bullish technical signal and strong profitability metrics including a 71.67% gross margin and 27.69% net income margin. Recent earnings show mixed results, with a beat in Q2 2026 but a miss in Q1 2026, while Q3 2026 results are pending. The company maintains robust cash flow from operations of $2.90B in 2025 and a solid balance sheet with $1.99B in cash. Analyst consensus is a Buy with a $87.33 price target, though sentiment is tempered by near-term competitive pressures.

The outlook for ZTS is cautiously optimistic, supported by industry-leading margins and a diversified product portfolio, but faces headwinds from U.S. companion animal market weakness and increased competition. Investment opportunity lies in its undervalued P/E of 11.92 relative to growth potential, while risks include pricing erosion and volume declines. The stock's current level near resistance at $74 suggests potential for consolidation before further gains.